Results 121 to 130 of about 26,604 (250)

Cord blood red cell concentrates for preterm neonate transfusion: Insights from the multicenter BORN trial

open access: yesTransfusion, EarlyView.
Abstract Background The BORN trial suggested that using cord blood‐red blood cells (CB‐RBCs) to transfuse severely preterm neonates significantly improves clinical outcomes compared to standard adult donor RBCs (A‐RBC). Study Design and Methods The study illustrates CB‐RBC concentrate production and inventory management across nine CB banks ...
Claudio Pellegrino   +38 more
wiley   +1 more source

A novel intronic variant ABO*AW allele resulting in weak A expression

open access: yes
Transfusion, EarlyView.
Yujung Jung   +8 more
wiley   +1 more source

Clinical application of a modified platelet desialylation test for mechanistic characterization of platelet transfusion refractoriness

open access: yesTransfusion, EarlyView.
Abstract Background Platelet transfusion refractoriness (PTR) is a major challenge in transfusion medicine and may result from both immune and non‐immune mechanisms. Although alloantibodies are well‐established contributors, Fc‐independent pathways such as platelet desialylation have emerged as alternative mechanisms of clearance.
Karen Ziza   +11 more
wiley   +1 more source

Hold on to your units: Quality of red cell concentrates is only affected after multiple transient warming events

open access: yesTransfusion, EarlyView.
Abstract Background Cryopreserved red cell concentrates (RCCs) glycerolized using a high glycerol (40%) method can be stored below −65°C for up to 30 years; however, units may be inadvertently warmed above −65°C due to freezer failures, human errors, or routine inventory management.
Jayme Kurach   +8 more
wiley   +1 more source

Relationship between ABO blood group and lymph node metastasis in colon cancer: a retrospective cohort study. [PDF]

open access: yesWorld J Surg Oncol
Ramírez-Giraldo C   +7 more
europepmc   +1 more source

Bacterial proliferation is comparable in red blood cell concentrates stored in DEHT/PAGGSM and DEHP/SAGM containers

open access: yesVox Sanguinis, EarlyView.
Abstract Background and Objectives The European Union's ban on the use of di(2‐ethylhexyl) phthalate (DEHP) in medical devices will take effect in 2030. DEHP is a plasticizer in polyvinyl chloride blood bags that helps stabilize the red blood cell membrane during hypothermic red blood cell concentrate (RBCC) storage.
Sandra Ramirez‐Arcos   +8 more
wiley   +1 more source

Addressing racial disparities in representation across blood, stem cell and organ and tissue donor pools

open access: yesVox Sanguinis, EarlyView.
Abstract Background and Objectives Adequate representation of donors from diverse ancestral populations in blood, stem cell and organ transplantation is critical to ensuring equitable access to these lifesaving therapies. Because of population‐level differences in genetic markers, patients from racialized groups may have unique transfusion and ...
Bonnie Lu   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy